Latest news

New film from Eiffage about Ironhand®

Bioservo publishes prospectus and invites to investor presentations (regulatory information)

World’s first soft robotic muscle strengthening system. Developed in collaboration with leading Fortune 500 companies

Menu

28 Jun, 2019  ·  Regulatory information

Jacob Michlewicz new CFO for Bioservo Technologies

Bioservo Technologies AB (publ) (Nasdaq First North: BIOS) announces today that the company has contracted Jacob Michlewicz as new interim CFO and member of the management team. He succeeds Maria Myräng as CFO and takes office on 4 August 2019.

Jacob has with his background as business consultant from McKinsey and later as co-founder of consulting firm Zitha Consulting been an advisor to Bioservo during the past year. Furthermore, Jacob obtained an MBA from the University of Michigan, Ann Arbor, USA.

Bioservo wants to thank the outgoing CFO Maria Myräng, who has decided to pursue a new opportunity outside the company, for her valuable contribution to Bioservo and wishes her all the best in the future.

About Bioservo Technologies

Bioservo Technologies (publ) is a technology and development company that combines medical science with modern robotics. The company holds a leading global position within soft exoskeleton technology – wearable non-invasive devices – for people in need of extra power to optimise the body’s endurance and performance, or for people with reduced muscle strength.

After many years of research and development, Bioservo Technologies is now focused on a commercialisation of the company’s products and patented technologies. The gloves are well-suited to medical rehabilitation, and to preventive use in a variety of industrial applications. The company has signed strategic cooperation agreements with several multinational companies within e.g. the automotive, aviation as well as the construction and infrastructure industry.

Bioservo Technologies was founded in 2006 through a collaboration between researchers at the Royal Institute of Technology and doctors at Karolinska University Hospital in Stockholm. Bioservo Technologies is a Swedish public limited company with its headquarters and operations based in Kista, north of Stockholm. FNCA Sweden AB, +46(0)8-528 00399, info@fnca.se, is the company’s Certified Adviser on Nasdaq First North. To learn more, please visit www.bioservo.com.

Contact:

Petter Bäckgren
CEO
Phone: +46 (0)8 21 17 10
petter.backgren@bioservo.com